These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of glycemic control and aldose reductase inhibition on nerve conduction velocity. Pfeifer MA Am J Med; 1985 Nov; 79(5A):18-23. PubMed ID: 3934964 [TBL] [Abstract][Full Text] [Related]
3. Clinical trials of sorbinil on nerve function. Pfeifer MA Metabolism; 1986 Apr; 35(4 Suppl 1):78-82. PubMed ID: 3083211 [TBL] [Abstract][Full Text] [Related]
4. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes. Jaspan JB; Towle VL; Maselli R; Herold K Metabolism; 1986 Apr; 35(4 Suppl 1):83-92. PubMed ID: 3083212 [TBL] [Abstract][Full Text] [Related]
5. Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy. Lewin IG; O'Brien IA; Morgan MH; Corrall RJ Diabetologia; 1984 Jun; 26(6):445-8. PubMed ID: 6432615 [TBL] [Abstract][Full Text] [Related]
6. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy. Jaspan JB; Herold K; Bartkus C Am J Med; 1985 Nov; 79(5A):24-37. PubMed ID: 3000176 [TBL] [Abstract][Full Text] [Related]
7. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Yue DK; Hanwell MA; Satchell PM; Turtle JR Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173 [TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil. O'Hare JP; Morgan MH; Alden P; Chissel S; O'Brien IA; Corrall RJ Diabet Med; 1988 Sep; 5(6):537-42. PubMed ID: 2974776 [TBL] [Abstract][Full Text] [Related]
9. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)]. Christensen JE; Larsen AB; Gregersen G Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975 [No Abstract] [Full Text] [Related]
10. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. Sima AA; Bril V; Nathaniel V; McEwen TA; Brown MB; Lattimer SA; Greene DA N Engl J Med; 1988 Sep; 319(9):548-55. PubMed ID: 3136331 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of aldose reductase in human diabetic neuropathy. Jaspan J Drugs; 1986; 32 Suppl 2():23-9. PubMed ID: 2431859 [TBL] [Abstract][Full Text] [Related]
12. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Engerman RL; Kern TS; Larson ME Diabetologia; 1994 Feb; 37(2):141-4. PubMed ID: 8163047 [TBL] [Abstract][Full Text] [Related]
13. Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity. Sima AA; Prashar A; Nathaniel V; Bril V; Werb MR; Greene DA Diabet Med; 1993 Mar; 10(2):115-21. PubMed ID: 8458187 [TBL] [Abstract][Full Text] [Related]
14. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat. Cameron NE; Leonard MB; Ross IS; Whiting PH Diabetologia; 1986 Mar; 29(3):168-74. PubMed ID: 3084324 [TBL] [Abstract][Full Text] [Related]
15. Effect of a new aldose reductase inhibitor, 8'-chloro-2',3'-dihydrospiro [pyrrolidine-3,6'(5'H)-pyrrolo[1,2,3-de] [1,4]benzoxazine]-2,5,5'- trione (ADN-138), on delayed motor nerve conduction velocity in streptozotocin-diabetic rats. Hirata Y; Fujimori S; Okada K Metabolism; 1988 Feb; 37(2):159-63. PubMed ID: 2828821 [TBL] [Abstract][Full Text] [Related]
17. Improvement in peripheral nerve function after one year of Sorbinil. Gieron MA; Malone JI; Lowitt S; Korthals JK Neuroreport; 1991 Jun; 2(6):348-50. PubMed ID: 1655107 [TBL] [Abstract][Full Text] [Related]
18. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Gillon KR; Hawthorne JN; Tomlinson DR Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913 [TBL] [Abstract][Full Text] [Related]